Windsor Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$304K Buy
263
+3
+1% +$3.54K 0.08% 105
2026
Q2
$312K Buy
260
+1
+0.4% +$1.02K 0.08% 104
2026
Q1
$238K Buy
259
+28
+12% +$28.4K 0.07% 112
2025
Q4
$248K Buy
+231
New +$221K 0.07% 107

Other funds holding LLY

Windsor Capital Management's LLY Position: Q3 2026 in Review

Windsor Capital Management increased its Eli Lilly (LLY) stake by 1.2% in Q3 2026, buying an estimated $3.54K and bringing the position to 263 shares worth $304K. The position accounts for 0.08% of the portfolio, ranked #105.

Windsor Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $312K in Q2 2026. 428 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Windsor Capital Management held 263 shares of Eli Lilly worth $304K as of Q3 2026.
  • Windsor Capital Management bought 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
  • Eli Lilly made up 0.08% of Windsor Capital Management's portfolio in Q3 2026, its #105 holding.
  • Windsor Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Windsor Capital Management's Eli Lilly position peaked at $312K in Q2 2026.
  • 428 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Windsor Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.